EXACT BIOCHIP CORP.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
The "Disposable-Gate Nanoelectronic Biomedical Detection Platform" technology is a world-leading, innovative detection method. Its sensitivity has reached the sub-fM (< 10^-15 M) level, which is over a thousand times higher than currently used detection methods, while reducing the detection time from several hours to just 20 minutes. The technical team has successfully completed validation for various target analytes, including Botulinum toxin, Hepatitis B antigen proteins, and Streptococcus pneumoniae. Featuring 8 channels with continuous scalability, this detection platform can simultaneously detect different biomarkers, providing an outstanding diagnostic tool for early-stage cancer and other diseases.
The content above was translated by Ai
Founded Year
2010
Unified Business No.
53273394
Status
Active
Number of Employees
0
Total Paid-in
Capital
16,400,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Shen Zheng Biotech was established through investments from multiple National Chiao Tung University alumni and owners of listed and OTC semiconductor companies in the Hsinchu Science Park. The Chairman is Mr. Kuei-Jui Li, President of Cheng-Hsien Technology Group, a world-renowned ophthalmic laser medical equipment manufacturer. Currently stationed in the National Chiao Tung University Incubation Center, the company is actively executing its global patent layout. Having acquired the technology transfer of the "Disposable-Gate Nanoelectronic Biomedical Detection Platform" from National Chiao Tung University, Shen Zheng Biotech can target early-stage cancer and disease etiology detection, becoming a powerful weapon in the fight against cancer and various viruses.
The content above was translated by Ai
